Usa India city Mumbai covid-19 outbreak Usa India city Mumbai

₹2500-3000 crore

Reading now: 835
www.livemint.com

MUMBAI: US private equity giant KKR & Co. Inc. has emerged as the front-runner to buy a 51% stake in JB Chemicals and Pharmaceuticals Ltd, which manufactures popular over-the-counter drugs rantac and metrogyl.

Two persons confirmed that the companies are in discussion. The proposed acquisition, which would include an open offer, could cost ₹2,500- ₹3,000 crore in an all cash deal that is likely within a month, said the first person. “The discussion is in advanced stages.

A premium of 10-20% to the market value of JB Chemicals can be expected because it is a bulk acquisition involving change in control.

The transaction should value the company at ₹5,000-6,000 crore," added the first person. KKR declined to comment on the development.

Read more on livemint.com
The website covid-19.rehab is an aggregator of news from open sources. The source is indicated at the beginning and at the end of the announcement. You can send a complaint on the news if you find it unreliable.

Related News

DMCA